Frontlight ResearchEarly access
Trial site
IONC - Instituto Oncologico de Cordoba
- 3running trials
- 1closed trial
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Cervical cancer1 trial
- Gastric and oesophageal cancer1 trial
- Phase
- Phase 34 trials
- Status
- Active, not recruiting2 trials
- Completed1 trial
- Recruiting1 trial
- Lead sponsor
- Amgen2 trials
- Seagen, a wholly owned subsidiary of Pfizer1 trial
- Shanghai Henlius Biotech1 trial
Running trials
Recruiting
Active, not recruiting
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026